<?xml version="1.0" encoding="utf-8" ?>
<INTERACTIONS>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>452-RETINOIDS.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="RETINOIDS" code="D05-D10" /></DRUG1>
<DRUG2>
<CLASS name="OTHER RETINOIDS" code="D05-D10" /></DRUG2>
<DESCRIPTION>Risk of symptoms evocative of hypervitaminosis A</DESCRIPTION>
<SEVERITY>CONTRAINDICATION</SEVERITY>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>452-RETINOIDS.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="RETINOIDS" code="D05-D10" /></DRUG1>
<DRUG2>
<CLASS name="TETRACYCLINE ANTIBIOTICS" code="J01AA" /></DRUG2>
<DESCRIPTION>Risk of intracranial hypertension</DESCRIPTION>
<SEVERITY>CONTRAINDICATION</SEVERITY>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>452-RETINOIDS.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="RETINOIDS" code="D05-D10" /></DRUG1>
<DRUG2>
<DRUG name="VITAMIN A" rxcui="11246">
<ATC code="A11C" />
<ATC code="A11CA" />
<ATC code="A11CA01" />
<ATC code="A11CA02" />
</DRUG>
</DRUG2>
<DESCRIPTION>Risk of symptoms evocative of hypervitaminosis A</DESCRIPTION>
<SEVERITY>CONTRAINDICATION</SEVERITY>
</INTERACTION>
</INTERACTIONS>
